|
🐢
|
Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients
9 auth.
A. Hachulla,
David Launay,
V. Gaxotte,
P. Groote,
N. Lamblin,
Patrick Devos,
...
P. Hatron,
J. Beregi,
E. Hachulla
|
8 |
2008 |
8
🐢
|
|
🐜
|
Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis.
17 auth.
P. Dieudé,
M. Guedj,
J. Wipff,
J. Avouac,
I. Fajardy,
E. Diot,
B. Granel,
J. Sibilia,
J. Cabane,
Luc Mouthon,
...
J. Cracowski,
Patrick Carpentier,
E. Hachulla,
O. Meyer,
André Kahan,
Catherine Boileau,
Y. Allanore
|
7 |
2009 |
7
🐜
|
|
🐜
|
Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature
13 auth.
M. R. Pokeerbux,
J. Giovannelli,
Luc Dauchet,
Luc Mouthon,
C. Agard,
Jean-Christophe Lega,
Y. Allanore,
Patrick Jego,
B. Bienvenu,
Sabine Berthier,
...
A. Mékinian,
E. Hachulla,
David Launay
|
7 |
2019 |
7
🐜
|
|
🐬
|
Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis.
Mohamed Hebbar,
J. Peyrat,
L. Hornez,
P. Hatron,
E. Hachulla,
B. Devulder
|
7 |
2000 |
7
🐬
|
|
🐜
|
Intravenous immunoglobulins for steroid‐refractory esophageal involvement related to polymyositis and dermatomyositis: A series of 73 patients
8 auth.
Isabella Marie,
Jean-François Ménard,
P. Hatron,
E. Hachulla,
Luc Mouthon,
K. Tiev,
...
Philippe Ducrotté,
Patrick Cherin
|
7 |
2010 |
7
🐜
|
|
🐜
|
The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis.
14 auth.
P. Dieudé,
M. Guedj,
J. Wipff,
J. Avouac,
E. Hachulla,
E. Diot,
B. Granel,
J. Sibilia,
J. Cabane,
O. Meyer,
...
Luc Mouthon,
A. Kahan,
Catherine Boileau,
Y. Allanore
|
6 |
2008 |
6
🐜
|
|
🐜
|
BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4.
22 auth.
P. Dieudé,
J. Wipff,
M. Guedj,
B. Ruiz,
Inga Melchers,
E. Hachulla,
G. Riemekasten,
E. Diot,
N. Hunzelmann,
J. Sibilia,
...
K. Tiev,
Luc Mouthon,
J. Cracowski,
Patrick Carpentier,
J. Distler,
Z. Amoura,
I. Tarner,
J. Avouac,
O. Meyer,
André Kahan,
Catherine Boileau,
Y. Allanore
|
6 |
2009 |
6
🐜
|
|
🐜
|
Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers
11 auth.
A. Bérézné,
Raphaèle Seror,
S. Morell-Dubois,
M. D. Menthon,
E. Fois,
A. Dzeing-Ella,
...
Christelle Nguyen,
E. Hachulla,
Loïc Guillevin,
Serge Poiraudeau,
Luc Mouthon
|
6 |
2011 |
6
🐜
|
|
🐜
|
Long‐term outcome of patients with polymyositis/ dermatomyositis and anti‐PM‐Scl antibody
13 auth.
Isabella Marie,
L. Lahaxe,
O. Benveniste,
K. Delavigne,
Daniel Adoue,
Luc Mouthon,
E. Hachulla,
Joël Constans,
K. Tiev,
Elisabeth Diot,
...
H. Levesque,
Olivier Boyer,
F. Jouen
|
6 |
2010 |
6
🐜
|
|
🐜
|
A descriptive and prognostic study of systemic sclerosis-associated myopathies
13 auth.
Brigitte Ranque,
François-Jérôme Authier,
V. Le-Guern,
C. Pagnoux,
A. Bérézné,
Y. Allanore,
D. Launay,
E. Hachulla,
André Kahan,
Jean Cabane,
...
Romain K. Gherardi,
Loïc Guillevin,
Luc Mouthon
|
6 |
2008 |
6
🐜
|
